Fentanyl Citrate Bupivacaine (Pharmedium) – glass particulate contamination (2016)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
2.5 mcg/mL Fentanyl Citrate and 0.0312% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in 250 mL Hospira LifeCare Bag, Service Code 2H9195, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-195-50
Brand
Pharmedium Services, LLC
Lot Codes / Batch Numbers
Lot Number 160890247M, Exp. Date 6/28/2016, Lot Number 160380151M, Exp. Date 5/8/2016, Lot Number 160490238M, Exp. Date 5/19/2016, Lot Number 160550208M, Exp. Date 5/25/2016, Lot Number 160610062M, Exp. Date 5/30/2016, Lot Number 160630184M, Exp. Date 6/2/2016, Lot Number 160700191M, Exp. Date 6/9/2016, Lot Number 160750045M, Exp. Date 6/13/2016, Lot Number 160770156M, Exp. Date 6/16/2016, Lot Number 160910163M, Exp. Date 6/30/2016, Lot Number 160810279M, Exp. Date 6/20/2016
Products Sold
Lot Number 160890247M , Exp. Date 6/28/2016 ; Lot Number 160380151M , Exp. Date 5/8/2016 ; Lot Number 160490238M , Exp. Date 5/19/2016 ; Lot Number 160550208M , Exp. Date 5/25/2016 ; Lot Number 160610062M , Exp. Date 5/30/2016 ; Lot Number 160630184M , Exp. Date 6/2/2016 ; Lot Number 160700191M , Exp. Date 6/9/2016 ; Lot Number 160750045M , Exp. Date 6/13/2016 ; Lot Number 160770156M , Exp. Date 6/16/2016 ; Lot Number 160910163M , Exp. Date 6/30/2016 ; Lot Number 160810279M , Exp. Date 6/20/2016 ;
Pharmedium Services, LLC is recalling 2.5 mcg/mL Fentanyl Citrate and 0.0312% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, due to Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026